SCHEMBL22649244

SCHEMBL22649244

CC(C)(C)OC(=O)[C@H](Cc1ccccc1)NC(=O)N(Cc1ccccc1)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.48
MAPT P10636 6/20 0.47
TDP1 Q9NUW8 4/20 0.47
POLB P06746 3/20 0.47
ITGA4 P13612 1/20 0.45
ITGB7 P26010 1/20 0.45
MAOA P21397 1/20 0.45
MLYCD O95822 1/20 0.44
MMP1 P03956 1/20 0.44
MMP3 P08254 1/20 0.44
MMP9 P14780 1/20 0.44
NPSR1 Q6W5P4 3/20 0.43
ATM Q13315 1/20 0.43
PSEN1 P49768 2/20 0.42
PSEN2 P49810 2/20 0.42
APH1B Q8WW43 2/20 0.42
NCSTN Q92542 2/20 0.42
APH1A Q96BI3 2/20 0.42
PSENEN Q9NZ42 2/20 0.42
KLK5 Q9Y337 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22649160 0.90 MEN1 (0.39) HCRTR1MAPTTDP1POLBITGA4
SCHEMBL22647598 0.90 PSEN1 (0.49) MAPTTDP1POLBNPSR1ATM
SCHEMBL29405291 0.90 PSEN1 (0.49) MAPTTDP1POLBNPSR1ATM
SCHEMBL22647600 0.90 PSEN1 (0.49) MAPTTDP1POLBNPSR1ATM
SCHEMBL22647455 0.90 APP (0.41) HCRTR1MAPTTDP1POLBITGA4
SCHEMBL29471100 0.90 APP (0.41) HCRTR1MAPTTDP1POLBITGA4
SCHEMBL22647465 0.89 ATM (0.50) POLBATMALDH1A1
SCHEMBL22647454 0.89 ATM (0.50) POLBATMALDH1A1
SCHEMBL29405787 0.89 ATM (0.50) POLBATMALDH1A1
SCHEMBL22649386 0.86 KLK5 (0.42) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200354404-A1 PEPTIDOMIMETIC AGENTS, SYNTHESIS AND USES THEREOF THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2020-11-12 US disclosed
WO-2020227588-A1 PEPTIDOMIMETIC AGENTS, SYNTHESIS AND USES THEREOF THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2020-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200354404-A1 PEPTIDOMIMETIC AGENTS, SYNTHESIS AND USES THEREOF DNPEP, PEPD, ANPEP HCRTR1 1792/4885MAPT 1777/4885TDP1 2924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.